These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD, Rowe M, Rickinson AB. J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [Abstract] [Full Text] [Related]
4. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus. Rooney C, Howe JG, Speck SH, Miller G. J Virol; 1989 Apr; 63(4):1531-9. PubMed ID: 2538644 [Abstract] [Full Text] [Related]
6. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G. J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717 [Abstract] [Full Text] [Related]
14. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H. Int J Cancer; 1993 Feb 20; 53(4):621-7. PubMed ID: 8382194 [Abstract] [Full Text] [Related]
15. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Menezes J, Leibold W, Klein G, Clements G. Biomedicine; 1975 Jul 20; 22(4):276-84. PubMed ID: 179629 [Abstract] [Full Text] [Related]
16. The Epstein-Barr virus carrier state: dominance of a single growth-transforming isolate in the blood and in the oropharynx of healthy virus carriers. Yao QY, Rowe M, Martin B, Young LS, Rickinson AB. J Gen Virol; 1991 Jul 20; 72 ( Pt 7)():1579-90. PubMed ID: 1649896 [Abstract] [Full Text] [Related]
17. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen. Ernberg I, Kallin B, Dillner J, Falk K, Ehlin-Henriksson B, Hammarskjöld ML, Klein G. Int J Cancer; 1986 Nov 15; 38(5):729-37. PubMed ID: 3021635 [Abstract] [Full Text] [Related]
18. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB. J Virol; 1989 Mar 15; 63(3):1031-9. PubMed ID: 2536817 [Abstract] [Full Text] [Related]
19. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. J Virol; 1990 Sep 15; 64(9):4084-92. PubMed ID: 2166806 [Abstract] [Full Text] [Related]
20. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5. Trivedi P, Cuomo L, de Campos-Lima PO, Imreh MP, Kvarnung K, Klein G, Masucci MG. J Gen Virol; 1993 Jul 15; 74 ( Pt 7)():1393-8. PubMed ID: 8393080 [Abstract] [Full Text] [Related] Page: [Next] [New Search]